Aelis Farma Strengthens its Leadership Team with the Appointment of Arsène Guekam as Chief Corporate Development OfficerPosted by On



BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain disorders, today announces the reinforcement of its leadership team with the appointment of Arsène Guekam as Chief Corporate Development Officer (CDO). With over 15 years of experience in the Healthcare (biotech/medtech) and financial sectors, Arsène Guekam brings an unvaluable expe



Source link

Business

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.